These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1691857)

  • 1. [Interaction between HIV and CD4 antigen and application of CD4 derivatives to AIDS therapy].
    Mizukami T
    Tanpakushitsu Kakusan Koso; 1990 Mar; 35(3):225-35. PubMed ID: 1691857
    [No Abstract]   [Full Text] [Related]  

  • 2. [Receptor of cells with infection of AIDS virus].
    Xu TG
    Sheng Li Ke Xue Jin Zhan; 1991 Jan; 22(1):29-33. PubMed ID: 1829542
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular biological bases of resistance to HIV/AIDS (the hypothesis with elements of the theory).
    Skripal IG
    Mikrobiol Z; 1995; 57(4):89-105. PubMed ID: 8548075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CD4-gp120 interaction and AIDS pathogenesis.
    Capon DJ; Ward RH
    Annu Rev Immunol; 1991; 9():649-78. PubMed ID: 1910691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes of gp120 in epitopes near the CCR5 binding site are induced by CD4 and a CD4 miniprotein mimetic.
    Zhang W; Canziani G; Plugariu C; Wyatt R; Sodroski J; Sweet R; Kwong P; Hendrickson W; Chaiken I
    Biochemistry; 1999 Jul; 38(29):9405-16. PubMed ID: 10413516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS and immune dysfunction. Alternative etiologic mechanisms.
    del Guercio P
    Contrib Microbiol Immunol; 1989; 11():289-304. PubMed ID: 2573482
    [No Abstract]   [Full Text] [Related]  

  • 7. The antigenic structure of the HIV gp120 envelope glycoprotein.
    Wyatt R; Kwong PD; Desjardins E; Sweet RW; Robinson J; Hendrickson WA; Sodroski JG
    Nature; 1998 Jun; 393(6686):705-11. PubMed ID: 9641684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
    Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
    Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1.
    Bower JF; Green TD; Ross TM
    Virology; 2004 Oct; 328(2):292-300. PubMed ID: 15464849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Binding of HIV-1 by "soluble" CD4 receptor--new therapeutic possibilities in AIDS].
    Nowak J
    Pol Tyg Lek; 1989 Apr; 44(17):401-2. PubMed ID: 2533976
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of HIV infection: perspectives].
    Monsuez JJ
    Pathol Biol (Paris); 1992 Jun; 40(6):609-20. PubMed ID: 1383913
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a new neutralizing epitope conformationally affected by the attachment of CD4 to gp120.
    Kang CY; Hariharan K; Posner MR; Nara P
    J Immunol; 1993 Jul; 151(1):449-57. PubMed ID: 7686944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell antigenic site mapping of HIV-1 glycoproteins.
    Neurath AR
    Chem Immunol; 1993; 56():34-60. PubMed ID: 8452653
    [No Abstract]   [Full Text] [Related]  

  • 14. Soluble CD4: another therapeutic option in HIV infection.
    Lancet; 1990 May; 335(8698):1128-30. PubMed ID: 1971867
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mechanism of resistance to HIV-1 entry: inefficient interactions of CXCR4 with CD4 and gp120 in macrophages.
    Dimitrov DS; Norwood D; Stantchev TS; Feng Y; Xiao X; Broder CC
    Virology; 1999 Jun; 259(1):1-6. PubMed ID: 10364484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
    Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
    Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant CD4 molecules with improved binding to HIV envelope protein gp120 selected by phage display.
    Krykbaev R; McKeating J; Jones I
    Virology; 1997 Aug; 234(2):196-202. PubMed ID: 9268150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroviral vectors expressing soluble CD4: a potential gene therapy for AIDS.
    Morgan RA; Looney DJ; Muenchau DD; Wong-Staal F; Gallo RC; Anderson WF
    AIDS Res Hum Retroviruses; 1990 Feb; 6(2):183-91. PubMed ID: 2328156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.